{"id":2937,"date":"2022-02-22T18:03:31","date_gmt":"2022-02-22T23:03:31","guid":{"rendered":"https:\/\/www.bu.edu\/reinhardlab\/?p=2937"},"modified":"2022-03-13T18:29:30","modified_gmt":"2022-03-13T22:29:30","slug":"congrats-on-hans-first-paper","status":"publish","type":"post","link":"https:\/\/www.bu.edu\/reinhardlab\/2022\/02\/22\/congrats-on-hans-first-paper\/","title":{"rendered":"Congrats on Han&#8217;s first paper!"},"content":{"rendered":"<p><img loading=\"lazy\" src=\"\/reinhardlab\/files\/2022\/02\/TOC3-330x300.png\" alt=\"\" width=\"242\" height=\"254\" class=\"wp-image-2942 aligncenter\" \/><\/p>\n<p>Congratulations to Han for having her paper <span>&#8220;Characterizing Lipid-Coated Mesoporous Silica Nanoparticles as CD169-Binding Delivery System for Rilpivirine and Cabotegravir&#8221; accepted by <em>Advanced NanoBiomed Research<\/em>!\u00a0<\/span><\/p>\n<p>In this work, we assess lipid-coated silica NPs as delivery vehicles for two antiretroviral drugs, <span>rilpivirine (RPV) and cabotegravir (CAB). This<\/span> work could have important relevance towards robust and long-term inhibition of retrovirus. <span>This is Han&#8217;s first paper published in her PhD and hopefully there will be more to come!<\/span><\/p>\n<p>Read the paper <a href=\"http:\/\/doi.org\/10.1002\/anbr.202100157\">here<\/a>.<\/p>\n<p>Read a relevant paper published by our group: <span><a href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acsami.1c17415\">Virus-Mimicking Polymer Nanoparticles Targeting CD169+ Macrophages as Long-Acting Nanocarriers for Combination Retrovirals.\u00a0<\/a>\u00a0<\/span><span>B. Eshaghi, J. Fofana, S. Nodder, S. Gummuluru, and B. M. Reinhard.\u00a0<\/span><span><em>ACS Appl. Mater. Interfaces<\/em><\/span><span>, (2021).<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Congratulations to Han for having her paper &#8220;Characterizing Lipid-Coated Mesoporous Silica Nanoparticles as CD169-Binding Delivery System for Rilpivirine and Cabotegravir&#8221; accepted by Advanced NanoBiomed Research!\u00a0 In this work, we assess lipid-coated silica NPs as delivery vehicles for two antiretroviral drugs, rilpivirine (RPV) and cabotegravir (CAB). This work could have important relevance towards robust and long-term [&hellip;]<\/p>\n","protected":false},"author":13874,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3895],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/posts\/2937"}],"collection":[{"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/users\/13874"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/comments?post=2937"}],"version-history":[{"count":3,"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/posts\/2937\/revisions"}],"predecessor-version":[{"id":2971,"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/posts\/2937\/revisions\/2971"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/media?parent=2937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/categories?post=2937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bu.edu\/reinhardlab\/wp-json\/wp\/v2\/tags?post=2937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}